570 results on '"Wegner, Florian"'
Search Results
2. The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis
3. Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
4. The comorbidity and co-medication profile of patients with progressive supranuclear palsy
5. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
6. The Progressive Supranuclear Palsy Clinical Deficits Scale
7. A Short Progressive Supranuclear Palsy Quality of Life Scale.
8. Impact of the Anticholinergic Burden on Disease-Specific Symptoms in Parkinsonian Syndromes.
9. Glycolic acid and D-lactate--putative products of DJ-1--restore neurodegeneration in FUS - and SOD1-ALS.
10. Neuroprotektive Therapien bei Tauopathien
11. Innate immune response to SARS‐CoV‐2 infection contributes to neuronal damage in human iPSC‐derived peripheral neurons
12. Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2
13. Decreased inflammatory cytokine production of antigen-specific CD4+ T cells in NMDA receptor encephalitis
14. Dopaminergic modulation of novelty repetition in Parkinson’s disease: A study of P3 event-related brain potentials
15. The cubic structure of Li3As stabilized by substitution – Li8TtAs4 (Tt = Si, Ge) and Li14TtAs6 (Tt = Si, Ge, Sn) and their lithium ion conductivity.
16. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer's disease brain.
17. The cubic structure of Li3As stabilized by substitution – Li8TtAs4 (Tt = Si, Ge) and Li14TtAs6 (Tt = Si, Ge, Sn) and their lithium ion conductivity
18. Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation
19. Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study
20. The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products
21. Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients
22. The comorbidity and co-medication profile of patients with progressive supranuclear palsy
23. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy
24. Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
25. Transcriptome-wide Profiling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures
26. Neural mechanisms underlying cognitive inflexibility in Parkinson's disease
27. Modeling Parkinson’s disease in midbrain-like organoids
28. Automatic covariance pattern analysis outperforms visual reading of 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy.
29. Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes.
30. Whole‐Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy.
31. iPSC-Derived Striatal Medium Spiny Neurons from Patients with Multiple System Atrophy Show Hypoexcitability and Elevated α-Synuclein Release
32. Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca2+ and GTPγS
33. Li3TrAs2 (Tr=Al, Ga, In) – Derivatives of the antifluorite type structure, conductivities and electronic structures
34. Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons
35. Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous PRKN-gene exon 2 and 4 deletions
36. Strategies to decrease injection site pain in botulinum toxin therapy
37. Li₃Tr As₂ ( Tr =Al, Ga, In) – Derivatives of the antifluorite type structure, conductivities and electronic structures
38. HOMER ‐3 Antibodies Were Not Detected in Two German Cohorts of Patients with Multiple System Atrophy
39. Absence of congruency sequence effects reveals neurocognitive inflexibility in Parkinson's disease
40. Inhibition of the cardiac Na+ channel α-subunit Nav1.5 by propofol and dexmedetomidine
41. Analysis of Parkinson’s Disease Outpatient Counselling for Advance Directive Creation: A Cross-Sectional Questionnaire-Based Survey of German General Practitioners and Neurologists
42. Front Cover: Li 3 As and Li 3 P revisited: DFT modelling on phase stability and ion conductivity (Z. Anorg. Allg. Chem. 11/2022)
43. The Molecular Basis for Species-specific Activation of Human TRPA1 Protein by Protons Involves Poorly Conserved Residues within Transmembrane Domains 5 and 6
44. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS
45. Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells
46. Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo
47. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels
48. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies
49. Li3TrAs2 (Tr=Al, Ga, In) – Derivatives of the antifluorite type structure, conductivities and electronic structures.
50. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.